Clinical trial
Oral Administration of Peptides; Absorption From Gastrointestinal Tract
NCT00468884 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00468884 |
|---|---|
| Title | Oral Administration of Peptides; Absorption From Gastrointestinal Tract |
| Official title | Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: a Proof of Concept Study in Healthy Subjects |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Increasing doses of GLP-1, PYY3-36 |
| Enrollment | 12 |
| Start date | Oct 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | May 3, 2007 |
| Last update posted | Oct 17, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: